西班牙语患者导航与Sanitas医疗中心西班牙语患者多目标便DNA测试的坚持之间的关联
Mallik Greene1, Timo Pew2, Shrey Gohil2
1Exact Sciences Corporation, 5505 Endeavor Ln, Madison, WI, 53719, USA. magreene@exactsciences.com.
概括
西班牙语患者导航在西班牙语患者中显著增加了多目标便DNA (mt-sDNA) 结肠直肠癌查的坚持,增长了4.4%. 文化定制的外展改善了服务不足人群的查参与.
科学领域:
- 公共卫生 公共卫生
- 健康差异 在健康上的差异
- 癌症查 癌症查
背景情况:
- 在西班牙语人口中,结肠直肠癌 (CRC) 查率低于最佳水平,通常是由于语言障碍.
- 需要有效的策略来改善不同患者群体的CRC查遵守率.
研究的目的:
- 评估西班牙语患者导航对西班牙语患者多目标便DNA (mt-sDNA) 测试的遵守的影响.
- 评估与英语外展 (ELO) 相比,西班牙语外展 (SLO) 和坚持之间的关联.
主要方法:
- 追溯分析mt-sDNA测试套件数据来自精确科学实验室LLC.
- 包括45-75岁的西班牙语患者,他们接受了mt-sDNA测试套件.
- 使用千平方测试和多变量逻辑回归,比较SLO和ELO组之间的坚持率.
主要成果:
- 与英语外展 (ELO) 组相比,西班牙语外展 (SLO) 组的坚持率绝对增加了4.4% (64.3%对59.9%,p=0.006).
- 在SLO组中,早期 (30天) 观察到更高的坚持,并在整个12个月的随访期间持续存在.
- 调整后勤回归表明,SLO与20%更高的坚持率相关 (OR=1.20,95% CI 1.05-1.37,p=0.007).
结论:
- 西班牙语患者导航是改善对mt-sDNA结肠直肠癌查的遵守的一个有效策略.
- 在文化和语言上量身定制的沟通增强了服务不足的人群的查参与.
- 有针对性的外展干预可以帮助减少癌症查中的健康差异.
相关概念视频
01:30Serum Laboratory Studies, Stool Test, Breath Test
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...